Christopher A. Barker

Tumor mutational load predicts survival after immunotherapy across multiple cancer types

Robert Samstein, Chung‐Han Lee, Alexander N. Shoushtari et al. · Nature Genetics · 2019 · 4.2K citations · Full text

Cancer Immunosurveillance, Tumor Heterogeneity, Medicine +9

Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma

Michael A. Postow, Margaret K. Callahan, Christopher A. Barker et al. · New England Journal of Medicine · 2012 · 2K citations · Full text

Immunology, Pathology, Dermatology +17

Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

Daniel G. Coit, John A. Thompson, Mark R. Albertini et al. · Journal of the National Comprehensive Cancer Network · 2019 · 432 citations · Full text

Tumor Biology, Surgical Oncology, Braf-targeted Therapy +15

Stereotactic Radiosurgery for Melanoma Brain Metastases in Patients Receiving Ipilimumab: Safety Profile and Efficacy of Combined Treatment

Ana P. Kiess, Jedd D. Wolchok, Christopher A. Barker et al. · International Journal of Radiation Oncology*Biology*Physics · 2015 · 383 citations · Full text

Neuro-oncology, Surgical Oncology, Radiation Therapy +9

NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021

Susan M. Swetter, John A. Thompson, Mark R. Albertini et al. · Journal of the National Comprehensive Cancer Network · 2021 · 327 citations · Full text

Nccn Guidelines® Insights, Surgical Oncology, Nccn Guidelines Insights +19